Both in Pharmaceuticals
Marker Therapeutics vs Allarity Therapeutics
Over the past year MRKR returned −1.0% and ALLR returned −34.9%; their daily moves had a correlation of 0.03.
MRKR −1.0% ALLR −34.9%Growth of $1, one year, split-adjusted
| Metric | MRKR | ALLR |
|---|---|---|
| Price | $1.00 | $0.9500 |
| Market cap | $16.7M | $15.1M |
| Today | +5.12% | +3.26% |
| 1 month | −9.1% | −1.6% |
| 6 months | −31.0% | −31.2% |
| Year to date | −32.9% | −12.0% |
| 1 year | −2.4% | −29.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 7.1× | 43.8× |
| Net cash | $11.3M | -$5.3M |
| Dividend yield | — | — |
| Volatility (60d) | 83.4% | 63.7% |
| Short % of float | 0.8% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).